Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate

Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate

Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:SN comprehensive clinical medicine 2020, Vol.2 (12), p.2509-2510
Hauptverfasser: Martelletti, Paolo, Bentivegna, Enrico, Luciani, Michelangelo, Spuntarelli, Valerio
Format: Artikel
Sprache:eng
Schlagworte:
Covid-19
Medicine
Medicine & Public Health
Topical Collection on COVID-19
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2510
container_issue 12
container_start_page 2509
container_title SN comprehensive clinical medicine
container_volume 2
creator Martelletti, Paolo
Bentivegna, Enrico
Luciani, Michelangelo
Spuntarelli, Valerio
description Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug–drug interactions (DDIs).
doi_str_mv 10.1007/s42399-020-00657-7
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7690334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33263101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2917-9ec7aba597b94f325b193f9f38a37066623742b1e3cc94790798cb86cbd7fcb73</originalsourceid><addsrcrecordid>eNp9kM1KAzEQx4MottS-gAfJC6Qmmd3N5iKUam2hoEj1GpI0225pNyXZFnx7t66WevEwzMD_Y-CH0C2jA0apuI8JBykJ5ZRQmqWCiAvU5SkHkksBl2d3B_VjXFNKOUuSlIpr1AHgGTDKumg4cXqh7cphHbHGr8EvKx_r0uKxtrUPuGhm9PIxfSRMDvC83Dpce_zmiDvozV7X7gZdFXoTXf9n99D7-Gk-mpDZy_N0NJwRyyUTRDortNGpFEYmBfDUMAmFLCDXIGiWZRxEwg1zYK1MhKRC5tbkmTULUVgjoIce2t7d3mzdwrqqDnqjdqHc6vCpvC7VX6UqV2rpD0pkkgIkTQFvC2zwMQZXnLKMqiNT1TJVDVP1zVQdv96dfz1Ffgk2BmgNsZGqpQtq7fehakj8V_sFrCaAaw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate</title><source>SpringerLink Journals - AutoHoldings</source><creator>Martelletti, Paolo ; Bentivegna, Enrico ; Luciani, Michelangelo ; Spuntarelli, Valerio</creator><creatorcontrib>Martelletti, Paolo ; Bentivegna, Enrico ; Luciani, Michelangelo ; Spuntarelli, Valerio</creatorcontrib><description>Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug–drug interactions (DDIs).</description><identifier>ISSN: 2523-8973</identifier><identifier>EISSN: 2523-8973</identifier><identifier>DOI: 10.1007/s42399-020-00657-7</identifier><identifier>PMID: 33263101</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Covid-19 ; Medicine ; Medicine &amp; Public Health ; Topical Collection on COVID-19</subject><ispartof>SN comprehensive clinical medicine, 2020, Vol.2 (12), p.2509-2510</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2917-9ec7aba597b94f325b193f9f38a37066623742b1e3cc94790798cb86cbd7fcb73</citedby><cites>FETCH-LOGICAL-c2917-9ec7aba597b94f325b193f9f38a37066623742b1e3cc94790798cb86cbd7fcb73</cites><orcidid>0000-0002-6556-4128</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s42399-020-00657-7$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s42399-020-00657-7$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,777,781,882,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33263101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martelletti, Paolo</creatorcontrib><creatorcontrib>Bentivegna, Enrico</creatorcontrib><creatorcontrib>Luciani, Michelangelo</creatorcontrib><creatorcontrib>Spuntarelli, Valerio</creatorcontrib><title>Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate</title><title>SN comprehensive clinical medicine</title><addtitle>SN Compr. Clin. Med</addtitle><addtitle>SN Compr Clin Med</addtitle><description>Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug–drug interactions (DDIs).</description><subject>Covid-19</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Topical Collection on COVID-19</subject><issn>2523-8973</issn><issn>2523-8973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9kM1KAzEQx4MottS-gAfJC6Qmmd3N5iKUam2hoEj1GpI0225pNyXZFnx7t66WevEwzMD_Y-CH0C2jA0apuI8JBykJ5ZRQmqWCiAvU5SkHkksBl2d3B_VjXFNKOUuSlIpr1AHgGTDKumg4cXqh7cphHbHGr8EvKx_r0uKxtrUPuGhm9PIxfSRMDvC83Dpce_zmiDvozV7X7gZdFXoTXf9n99D7-Gk-mpDZy_N0NJwRyyUTRDortNGpFEYmBfDUMAmFLCDXIGiWZRxEwg1zYK1MhKRC5tbkmTULUVgjoIce2t7d3mzdwrqqDnqjdqHc6vCpvC7VX6UqV2rpD0pkkgIkTQFvC2zwMQZXnLKMqiNT1TJVDVP1zVQdv96dfz1Ffgk2BmgNsZGqpQtq7fehakj8V_sFrCaAaw</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Martelletti, Paolo</creator><creator>Bentivegna, Enrico</creator><creator>Luciani, Michelangelo</creator><creator>Spuntarelli, Valerio</creator><general>Springer International Publishing</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6556-4128</orcidid></search><sort><creationdate>2020</creationdate><title>Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate</title><author>Martelletti, Paolo ; Bentivegna, Enrico ; Luciani, Michelangelo ; Spuntarelli, Valerio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2917-9ec7aba597b94f325b193f9f38a37066623742b1e3cc94790798cb86cbd7fcb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Covid-19</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Topical Collection on COVID-19</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martelletti, Paolo</creatorcontrib><creatorcontrib>Bentivegna, Enrico</creatorcontrib><creatorcontrib>Luciani, Michelangelo</creatorcontrib><creatorcontrib>Spuntarelli, Valerio</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>SN comprehensive clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martelletti, Paolo</au><au>Bentivegna, Enrico</au><au>Luciani, Michelangelo</au><au>Spuntarelli, Valerio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate</atitle><jtitle>SN comprehensive clinical medicine</jtitle><stitle>SN Compr. Clin. Med</stitle><addtitle>SN Compr Clin Med</addtitle><date>2020</date><risdate>2020</risdate><volume>2</volume><issue>12</issue><spage>2509</spage><epage>2510</epage><pages>2509-2510</pages><issn>2523-8973</issn><eissn>2523-8973</eissn><abstract>Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug–drug interactions (DDIs).</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>33263101</pmid><doi>10.1007/s42399-020-00657-7</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-6556-4128</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2523-8973
ispartof SN comprehensive clinical medicine, 2020, Vol.2 (12), p.2509-2510
issn 2523-8973
2523-8973
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7690334
source SpringerLink Journals - AutoHoldings
subjects Covid-19
Medicine
Medicine & Public Health
Topical Collection on COVID-19
title Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T20%3A23%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Headache%20as%20a%20Prognostic%20Factor%20for%20COVID-19.%20Time%20to%20Re-evaluate&rft.jtitle=SN%20comprehensive%20clinical%20medicine&rft.au=Martelletti,%20Paolo&rft.date=2020&rft.volume=2&rft.issue=12&rft.spage=2509&rft.epage=2510&rft.pages=2509-2510&rft.issn=2523-8973&rft.eissn=2523-8973&rft_id=info:doi/10.1007/s42399-020-00657-7&rft_dat=%3Cpubmed_cross%3E33263101%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33263101&rfr_iscdi=true